These findings prompt a reevaluation of Grem2's role in obesity and T2D, proposing that increased circulating Grem2 in obesity may act as a defensive response to counteract glucose homeostasis disturbances. Here, GREM2 is linked to obesity due to melanocortin 4 receptor deficiency.